"Target Cancer": A New York Times Report

[wisgrdnr]

Historically, advanced melanoma cancer certainly poses a heretofore "within a year" death sentence for those dioagnosed with this formidable cellular adversary.

A promising Roche drug in Stage one trials has stretched the timeframe of survivalbility for many, then the cancer ultimately found another pathway to gain the opportunity to reproduce once more.

The New York Times report, "Target Cancer" follows the progress that several of those patients in these experimental clinical trials encountered. It is a story of the ultimate human battle against a tenacious and unfortunately, unjchallengeable malignancy.

thewisegardener.com thanks the New York Times Company for a link to this important content. It is a true public service report of the highest human caliber!

http://www.nytimes.com/2010/02/24/health/research/24trial.html?partner=rss&emc=rss
_________________
www.palmdoctor.com & www.tropicriverwoods.com